Catalyst

Slingshot members are tracking this event:

Clovis (CLVS) Expects ARIEL3 Pivotal Maintenance Study Data in Mid-2017 Evaluating Rucaparib in Ovarian Cancer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CLVS

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 23, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ariel3, Pivotal Maintenance Study, Rucaparib, Ovarian Cancer